Angello Lin

Concepts (142)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Transplantation
18
2022
839
1.450
Why?
Pancreas Transplantation
7
2021
71
1.180
Why?
Intestinal Perforation
1
2020
35
0.730
Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
47
0.710
Why?
Graft Survival
10
2022
465
0.390
Why?
Renal Insufficiency
2
2020
121
0.280
Why?
Aminoimidazole Carboxamide
1
2004
25
0.240
Why?
Postoperative Complications
5
2020
1615
0.230
Why?
Reperfusion Injury
2
2013
320
0.220
Why?
Graft Rejection
6
2021
458
0.200
Why?
Blood Glucose
3
2014
631
0.190
Why?
Rituximab
1
2020
61
0.180
Why?
Methotrexate
1
2020
91
0.180
Why?
Tissue and Organ Procurement
1
2022
164
0.170
Why?
Transplant Recipients
1
2020
109
0.170
Why?
Patient Selection
2
2020
592
0.160
Why?
Delayed Graft Function
2
2022
39
0.160
Why?
Immunosuppressive Agents
5
2009
514
0.150
Why?
Liver Transplantation
2
2013
400
0.150
Why?
Nephrectomy
2
2009
103
0.140
Why?
Male
18
2021
37321
0.140
Why?
Health Services Accessibility
1
2020
581
0.130
Why?
Insulin
2
2012
619
0.130
Why?
Thrombocytopenia
2
2008
122
0.130
Why?
Heparin
2
2008
205
0.130
Why?
Middle Aged
11
2020
21147
0.130
Why?
Living Donors
2
2009
160
0.120
Why?
Kidney
3
2022
945
0.120
Why?
Kidney Diseases
2
2009
307
0.120
Why?
Liver Failure
1
2013
27
0.110
Why?
Retrospective Studies
9
2022
7277
0.110
Why?
Benchmarking
1
2013
91
0.110
Why?
Fatty Liver
1
2013
97
0.110
Why?
Adult
14
2022
21403
0.110
Why?
Quality Indicators, Health Care
1
2013
136
0.110
Why?
Antilymphocyte Serum
2
2009
52
0.110
Why?
Humans
21
2022
68618
0.100
Why?
Telemedicine
1
2020
700
0.100
Why?
Perioperative Care
1
2013
100
0.100
Why?
Hyperglycemia
2
2014
158
0.090
Why?
Biomarkers
1
2014
1593
0.080
Why?
Quality Improvement
1
2013
413
0.080
Why?
Female
15
2021
38074
0.080
Why?
Inflammation
1
2014
1030
0.080
Why?
Budd-Chiari Syndrome
1
2008
7
0.080
Why?
Granuloma, Plasma Cell
1
2007
8
0.070
Why?
Algorithms
1
2013
1196
0.070
Why?
Creatinine
2
2004
243
0.070
Why?
Cholestasis
1
2007
90
0.070
Why?
Treatment Outcome
8
2014
7029
0.070
Why?
Diabetes Mellitus
1
2012
694
0.070
Why?
Thrombosis
1
2008
218
0.070
Why?
Anticoagulants
2
2008
356
0.070
Why?
Antibodies, Monoclonal
1
2009
511
0.070
Why?
Peptide Fragments
1
2008
483
0.060
Why?
Liver Diseases
1
2007
193
0.060
Why?
Raffinose
1
2004
28
0.060
Why?
Allopurinol
1
2004
36
0.060
Why?
Ribonucleotides
1
2004
26
0.060
Why?
Organ Preservation Solutions
1
2004
45
0.060
Why?
Organ Preservation
1
2004
69
0.060
Why?
Transplantation, Autologous
1
2004
145
0.060
Why?
Adenovirus Infections, Human
1
2003
4
0.060
Why?
Nitric Oxide Synthase Type II
1
2004
201
0.060
Why?
Adenosine
1
2004
165
0.060
Why?
Nitric Oxide Synthase
1
2004
163
0.060
Why?
Sirolimus
1
2004
118
0.060
Why?
Ribavirin
1
2003
27
0.060
Why?
Dogs
1
2004
490
0.060
Why?
Immunoglobulins, Intravenous
1
2003
52
0.060
Why?
Aged
5
2020
14862
0.050
Why?
Glutathione
1
2004
343
0.050
Why?
Policy
1
2022
58
0.050
Why?
Immunohistochemistry
1
2004
1174
0.050
Why?
Tumor Necrosis Factor-alpha
1
2004
626
0.050
Why?
Antiviral Agents
1
2003
211
0.050
Why?
Acetylcysteine
1
2004
296
0.050
Why?
Smoking
1
2009
1452
0.050
Why?
Tissue Donors
1
2022
195
0.040
Why?
Waiting Lists
1
2020
104
0.040
Why?
Interleukin-2 Receptor alpha Subunit
2
2009
32
0.040
Why?
Multivariate Analysis
2
2013
1046
0.040
Why?
Referral and Consultation
1
2020
383
0.040
Why?
Length of Stay
2
2013
780
0.040
Why?
Longitudinal Studies
1
2021
1054
0.040
Why?
Young Adult
3
2013
5717
0.040
Why?
Apoptosis
1
2004
1641
0.040
Why?
Disease Models, Animal
1
2004
2550
0.040
Why?
Obesity
1
2003
1076
0.030
Why?
Cohort Studies
2
2014
2358
0.030
Why?
Cross-Sectional Studies
1
2022
2279
0.030
Why?
Prognosis
2
2013
2093
0.030
Why?
Adolescent
3
2013
8912
0.030
Why?
Follow-Up Studies
2
2013
3259
0.030
Why?
Hypoglycemia
1
2014
72
0.030
Why?
Interleukin-10
1
2014
144
0.030
Why?
C-Reactive Protein
1
2014
180
0.030
Why?
Interleukin-6
1
2014
330
0.030
Why?
Drug Administration Routes
1
2012
25
0.030
Why?
Child, Preschool
2
2013
3187
0.030
Why?
ROC Curve
1
2013
392
0.030
Why?
Linear Models
1
2013
521
0.030
Why?
Risk Factors
2
2014
5731
0.030
Why?
Patient Readmission
1
2013
267
0.020
Why?
Diabetic Nephropathies
1
2012
161
0.020
Why?
Databases, Factual
1
2013
622
0.020
Why?
Survival Rate
1
2013
1056
0.020
Why?
Registries
1
2013
733
0.020
Why?
Logistic Models
1
2013
1420
0.020
Why?
Hypoglycemic Agents
1
2012
362
0.020
Why?
Child
2
2013
6405
0.020
Why?
Pilot Projects
1
2012
1342
0.020
Why?
Risk
1
2009
563
0.020
Why?
Hirudins
1
2008
32
0.020
Why?
Factor V
1
2008
20
0.020
Why?
Partial Thromboplastin Time
1
2008
57
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
151
0.020
Why?
Severity of Illness Index
1
2013
1851
0.020
Why?
Recombinant Fusion Proteins
1
2009
376
0.020
Why?
Blood Coagulation
1
2008
123
0.020
Why?
Hepatectomy
1
2007
58
0.020
Why?
Animals
1
2004
20881
0.020
Why?
Proportional Hazards Models
1
2009
792
0.020
Why?
Immunoglobulin G
1
2009
481
0.020
Why?
Health Status
1
2009
429
0.020
Why?
Recombinant Proteins
1
2008
742
0.020
Why?
Prospective Studies
1
2013
3705
0.020
Why?
Platelet Count
1
2005
100
0.020
Why?
Aged, 80 and over
1
2013
4848
0.010
Why?
Reproducibility of Results
1
2009
2077
0.010
Why?
Dose-Response Relationship, Drug
1
2008
1745
0.010
Why?
Immunocompromised Host
1
2003
55
0.010
Why?
Infusions, Intravenous
1
2003
334
0.010
Why?
Tacrolimus
1
2003
127
0.010
Why?
Liver
1
2008
1118
0.010
Why?
Drug Therapy, Combination
1
2003
649
0.010
Why?
Biopsy
1
2003
540
0.010
Why?
United States
1
2013
7367
0.010
Why?
Body Mass Index
1
2003
867
0.010
Why?
Magnetic Resonance Imaging
1
2007
2223
0.010
Why?
Infant
1
2004
2891
0.010
Why?
Time Factors
1
2003
4655
0.010
Why?
Lin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (142)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_